| Not Yet Recruiting | Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) Metastatic NSCLC - Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2026-07-01 |
| Recruiting | Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) Recurrent Prostate Cancer | Phase 2 | 2026-05-01 |
| Recruiting | Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older Metastatic NSCLC - Non-Small Cell Lung Cancer | Phase 2 | 2026-04-10 |
| Not Yet Recruiting | Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 2 | 2026-03-01 |
| Recruiting | Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk So Sarcoma,Soft Tissue | Phase 2 | 2025-10-27 |
| Recruiting | NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline Breast Cancer | Phase 2 | 2025-07-16 |
| Recruiting | Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SA Triple-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer | Phase 2 | 2024-10-24 |
| Recruiting | Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2024-10-22 |
| Active Not Recruiting | LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma Non-hodgkin Lymphoma, B Cell | N/A | 2024-03-12 |
| Recruiting | Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients Non-small Cell Lung Cancer (NSCLC), Stage IV | N/A | 2023-12-21 |
| Active Not Recruiting | Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC Bladder Cancer | Phase 2 | 2022-06-24 |
| Active Not Recruiting | Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab i Small Cell Lung Cancer, Lung Cancer | Phase 2 | 2021-06-25 |
| Active Not Recruiting | Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. Diffuse Large B-cell Lymphoma | Phase 2 | 2021-06-25 |
| Terminated | Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2021-05-28 |
| Completed | SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II Malignant Pleural Mesothelioma, Non-small Cell Lung Cancer | Phase 2 | 2021-03-17 |
| Completed | Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. Advanced Solid Tumors | Phase 1 / Phase 2 | 2020-10-12 |
| Active Not Recruiting | Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer, NSCLC | Phase 2 | 2020-07-15 |
| Terminated | Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma | Phase 1 | 2019-11-04 |
| Terminated | Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for interme Prostate Cancer | Phase 3 | 2019-08-27 |
| Active Not Recruiting | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma Seminoma, Testicular Cancer | Phase 2 | 2019-07-29 |
| Terminated | Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC) Squamous-cell Non-small Cell Lung Cancer | Phase 2 | 2019-07-25 |
| Terminated | Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC Breast Cancer | Phase 3 | 2019-06-25 |
| Completed | Activity Program During Aromatase Inhibitor Therapy Early Breast Cancer | N/A | 2019-03-28 |
| Terminated | Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL Relapsed/Refractory Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | 2019-03-11 |
| Active Not Recruiting | 1st Line Durvalumab in PS 2 NSCLC Patients NSCLC Stage IV, NSCLC Stage IIIB | Phase 2 | 2018-12-04 |
| Terminated | TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2018-11-12 |
| Terminated | NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma Soft Tissue Sarcoma | Phase 1 / Phase 2 | 2018-10-02 |
| Terminated | Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma Refractory Multiple Myeloma | Phase 2 | 2018-10-01 |
| Completed | Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Uro Urothelial Cancer | Phase 2 | 2018-05-15 |
| Completed | Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2017-12-13 |
| Terminated | SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy Prostate Cancer | Phase 2 | 2017-10-24 |
| Completed | Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma, Advanced | Phase 2 | 2017-09-28 |
| Completed | Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. Advanced Non-small Cell Lung Cancer, KRAS Gene Mutation, Lung Cancer | Phase 1 | 2017-04-12 |
| Terminated | ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. Prostate Cancer Metastatic, Prostate Cancer | Phase 2 | 2017-03-31 |
| Terminated | Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Rectal Cancer | Phase 1 | 2017-02-22 |
| Completed | Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients Follicular Lymphoma | Phase 1 | 2017-02-15 |
| Terminated | Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Brea Breast Cancer | Phase 2 | 2016-10-28 |
| Completed | Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) NSCLC Non-small Cell Lung Cancer | Phase 2 | 2016-06-16 |
| Terminated | CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer Metastatic Breast Adenocarcinoma, Breast Cancer | Phase 2 | 2016-06-14 |
| Terminated | Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutam Cancer of the Prostate, Prostate Cancer | Phase 2 | 2016-06-10 |
| Terminated | Adjuvant Aspirin Treatment for Colon Cancer Patients Colon Cancer | Phase 3 | 2016-06-09 |
| Terminated | Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy Metastatic Colorectal Cancer | N/A | 2016-03-17 |
| Terminated | Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma Follicular Lymphoma | Phase 2 | 2015-11-06 |
| Completed | VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer Bladder Cancer | Phase 1 / Phase 2 | 2015-09-08 |
| Terminated | Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2015-08-31 |
| Terminated | Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer Breast Cancer, Adenocarcinoma | Phase 2 | 2015-08-17 |
| Completed | Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation Myeloproliferative Neoplasm, Primary Myelofibrosis, Essential Thrombocythemia | Phase 2 | 2015-04-01 |
| Completed | Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer Breast Cancer | Phase 3 | 2015-03-18 |
| Completed | Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma Myeloma | Phase 2 | 2014-12-02 |
| Active Not Recruiting | Prostate Cancer Biobank Prostatic Neoplasms | — | 2014-11-04 |
| Withdrawn | Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents Prostate Cancer | Phase 3 | 2014-08-19 |
| Active Not Recruiting | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases | Phase 3 | 2014-07-16 |
| Completed | Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC Small-Cell Lung Cancer | N/A | 2014-07-11 |
| Completed | Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer Breast Cancer | — | 2013-09-01 |
| Completed | LDE225 and Paclitaxel in Solid Tumors Solid Tumor, Ovarian Cancer | Phase 1 | 2013-09-01 |
| Completed | Trastuzumab & Pertuzumab Followed by T-DM1 in MBC Metastatic Breast Cancer | Phase 2 | 2013-03-03 |
| Terminated | Cetuximab for Elderly Patients With mCRC Metastatic Colorectal Cancer | Phase 2 | 2012-11-01 |
| Completed | Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progres Prostate Cancer | Phase 3 | 2012-09-01 |
| Terminated | Therapy De-escalation in Seminoma Stage IIA/B Seminoma | Phase 2 | 2012-06-15 |
| Terminated | Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2012-02-23 |
| Terminated | Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma Lymphoma | Phase 2 | 2011-02-09 |
| Completed | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery Prostate Cancer | Phase 3 | 2011-01-06 |
| Completed | Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostat Prostate Cancer | Phase 2 | 2010-12-23 |
| Completed | Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aro Breast Cancer | Phase 2 | 2010-08-01 |
| Completed | Metronomic Therapy in Metastatic Breast Cancer. Breast Cancer | Phase 3 | 2010-07-19 |
| Completed | Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Canc Leukemia, Lymphoma, Mature T-cell and Nk-cell Neoplasms | Phase 1 | 2010-07-01 |
| Completed | Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patient Lung Cancer | Phase 2 | 2010-06-01 |
| Completed | Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With L Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer | Phase 3 | 2010-05-27 |
| Completed | Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC) Lung Cancer | Phase 2 | 2010-05-03 |
| Terminated | Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Ca Liver Cancer | Phase 1 / Phase 2 | 2010-02-01 |
| Completed | Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Ce Lung Cancer | Phase 2 | 2010-01-01 |
| Completed | Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer | Phase 2 | 2009-11-01 |
| Completed | Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer Prostate Cancer | Phase 2 | 2009-09-14 |
| Completed | F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Lip Breast Cancer, Palmar-plantar Erythrodysesthesia | Phase 3 | 2009-09-01 |
| Completed | Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma Lymphoma | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Colorectal Cancer | Phase 1 / Phase 2 | 2009-03-01 |
| Completed | Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cance Colorectal Cancer | Phase 2 | 2008-11-01 |
| Completed | Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Liver Cancer | Phase 1 / Phase 2 | 2008-11-01 |
| Completed | Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Leukemia | Phase 2 | 2008-07-01 |
| Completed | Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 2 | 2008-06-01 |
| Completed | Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors Gastrointestinal Stromal Tumor | Phase 2 | 2008-01-22 |
| Completed | Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Melanoma (Skin) | Phase 2 | 2007-12-01 |
| Terminated | Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 2007-11-26 |
| Completed | PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, V Lymphoma | N/A | 2007-09-01 |
| Completed | Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma Lymphoma | Phase 2 | 2007-08-01 |
| Completed | Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Liver Cancer | Phase 2 | 2007-07-01 |
| Completed | E-MOSAIC Electronic Tool to Monitor Symptoms Cancer | — | 2007-02-01 |
| Completed | Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal C Esophageal Cancer | Phase 1 / Phase 2 | 2007-01-01 |
| Completed | Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Brea Breast Cancer | Phase 2 | 2006-12-01 |
| Completed | Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Tre Lymphoma | Phase 1 | 2006-10-01 |
| Completed | Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Lung Cancer | Phase 2 | 2006-01-01 |
| Completed | Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients W Malignant Mesothelioma | Phase 2 | 2005-11-14 |
| Completed | Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer Colorectal Cancer | Phase 3 | 2005-07-01 |
| Completed | Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphom Lymphoma | Phase 2 | 2005-06-01 |
| Completed | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer T Colorectal Cancer | Phase 1 / Phase 2 | 2005-05-01 |
| Completed | Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases Lung Cancer, Metastatic Cancer | Phase 2 | 2005-05-01 |
| Completed | Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer Breast Cancer | Phase 2 | 2005-05-01 |
| Completed | Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma Lymphoma | Phase 3 | 2004-06-08 |
| Completed | Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2004-06-01 |
| Completed | Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Esophageal Cancer | Phase 2 | 2004-03-01 |
| Completed | Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or S Lung Cancer | Phase 2 | 2003-11-01 |
| Completed | Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Bili Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer | Phase 2 | 2003-04-01 |
| Completed | Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Local Esophageal Cancer | Phase 2 | 2003-03-01 |
| Completed | Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Tr Leukemia | Phase 2 | 2002-06-01 |
| Completed | Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSC Lung Cancer | Phase 2 | 2001-09-01 |
| Completed | Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer Prostate Cancer | Phase 2 | 2001-08-01 |
| Completed | Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 3 | 2001-06-01 |
| Completed | Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients Lung Cancer | Phase 3 | 2001-04-04 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2001-02-01 |
| Completed | Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 3 | 2000-08-01 |
| Completed | Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung Malignant Mesothelioma | Phase 2 | 2000-06-01 |
| Completed | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2000-05-01 |
| Completed | Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Prostate Cancer | Phase 2 | 2000-03-01 |
| Completed | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer Gastric Cancer | Phase 3 | 1999-11-01 |
| Terminated | Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 Breast Cancer | Phase 3 | 1999-08-30 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer Gastric Cancer | Phase 2 | 1999-08-01 |
| Completed | Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 / Phase 2 | 1999-06-01 |
| Completed | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone In Breast Cancer | Phase 1 / Phase 2 | 1999-03-01 |
| Completed | Biological Therapy in Treating Patients With Bladder Cancer Bladder Cancer | Phase 3 | 1998-11-01 |
| Completed | Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia Leukemia | Phase 3 | 1998-09-01 |
| Completed | Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy Leukemia | Phase 2 | 1998-02-01 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma Lymphoma | Phase 3 | 1998-01-01 |
| Completed | Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia Leukemia | Phase 1 / Phase 2 | 1998-01-01 |
| Completed | Vinorelbine in Treating Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 2 | 1997-10-01 |
| Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed A Lymphoma | Phase 3 | 1997-04-01 |
| Completed | Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1997-04-01 |
| Completed | Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer Ovarian Cancer | Phase 3 | 1996-07-01 |
| Completed | Drugs to Reduce the Side Effects of Chemotherapy Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | 1996-05-01 |
| Completed | Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer Head and Neck Cancer | Phase 3 | 1994-04-01 |
| Completed | Chemotherapy in Treating Patients With Advanced Sarcoma Ovarian Cancer, Sarcoma | Phase 2 | 1993-01-01 |